Inhibition of WNK signaling with WNK463, an allosteric inhibitor of WNK kinase activity (Yamada et al., 2016; Zhang et al., 2016), significantly decreased expression of the EMT-related factor N-cadherin in breast cancer cells (Jaykumar et al., 2021). The gene discussed is CDH2; the disease is breast carcinoma.